Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center

Steiner S, Fehrer A, Hoheisel F, Schoening S, Aschenbrenner A, Babel N, Bellmann-Strobl J, Finke C, Fluge Ø, Froehlich L, Goebel A, Grande B, Haas JP, Hohberger B, Jason LA, Komaroff AL, Lacerda E, Liebl M, Maier A, Mella O, Nacul L, Paul F, Prusty BK, Puta C, Riemekasten G, Ries W, Rowe PC, Sawitzki B, Shoenfeld Y, Schultze JL, Seifert M, Sepúlveda N, Sotzny F, Stein E, Stingl M, Ufer F, Veauthier C, Westermeier F, Wirth K, Wolfarth B, Zalewski P, Behrends U, Scheibenbogen C (2023)

Publication Type: Journal article, Review article

Publication year: 2023

Journal

Book Volume: 22

Article Number: 103452

Journal Issue: 11

DOI: 10.1016/j.autrev.2023.103452

Abstract

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a devastating disease affecting millions of people worldwide. Due to the 2019 pandemic of coronavirus disease (COVID-19), we are facing a significant increase of ME/CFS prevalence. On May 11th to 12th, 2023, the second international ME/CFS conference of the Charité Fatigue Center was held in Berlin, Germany, focusing on pathomechanisms, diagnosis, and treatment. During the two-day conference, more than 100 researchers from various research fields met on-site and over 700 attendees participated online to discuss the state of the art and novel findings in this field. Key topics from the conference included: the role of the immune system, dysfunction of endothelial and autonomic nervous system, and viral reactivation. Furthermore, there were presentations on innovative diagnostic measures and assessments for this complex disease, cutting-edge treatment approaches, and clinical studies. Despite the increased public attention due to the COVID-19 pandemic, the subsequent rise of Long COVID-19 cases, and the rise of funding opportunities to unravel the pathomechanisms underlying ME/CFS, this severe disease remains highly underresearched. Future adequately funded research efforts are needed to further explore the disease etiology and to identify diagnostic markers and targeted therapies.

Authors with CRIS profile

Involved external institutions

Charité - Universitätsmedizin Berlin Germany (DE) ME/CFS Research Foundation gGmbH Germany (DE) Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Germany (DE) Universität zu Lübeck Germany (DE) Haukeland University Hospital / Haukeland universitetssykehus Norway (NO) FernUniversität in Hagen Germany (DE) The University of Liverpool United Kingdom (GB) Kinderklinik Garmisch-Partenkirchen / Deutsches Zentrum für Kinder- und Jugendrheumatologie / Kinder-Rheumaklinik / German Center for Pediatric and Adolescent Rheumatology Germany (DE) DePaul University United States (USA) (US) Veterans Affairs Healthcare System Boston and Harvard Medical School United States (USA) (US) London School of Hygiene and Tropical Medicine United Kingdom (GB) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Germany (DE) Max-Delbrück-Centrum für Molekulare Medizin / Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch Germany (DE) Julius-Maximilians-Universität Würzburg Germany (DE) Friedrich-Schiller-Universität Jena Germany (DE) Diakonissenkrankenhaus Flensburg Germany (DE) Johns Hopkins University (JHU) United States (USA) (US) Berliner Institut für Gesundheitsforschung (BIH) Germany (DE) Reichman University / אוניברסיטת רייכמן Israel (IL) Facharztzentrum Votivpark Austria (AT) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) Universities of Applied Sciences Joanneum / FH Joanneum Austria (AT) Universitätsklinikum Frankfurt am Main (KGU) Germany (DE) Nicolaus Copernicus University (NCU) / Uniwersytet Mikołaja Kopernika w Toruniu (UMK) Poland (PL) Technische Universität München (TUM) Germany (DE) Warsaw University of Technology / Politechnika Warszawska Poland (PL)

How to cite

APA:

Steiner, S., Fehrer, A., Hoheisel, F., Schoening, S., Aschenbrenner, A., Babel, N.,... Scheibenbogen, C. (2023). Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. Autoimmunity Reviews, 22(11). https://doi.org/10.1016/j.autrev.2023.103452

MLA:

Steiner, Sophie, et al. "Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center." Autoimmunity Reviews 22.11 (2023).

BibTeX: Download